The increasing production of essential oils has generated a significant amount of vegetal waste that must be discarded, increasing costs for farmers. In this context, fungi, due to their ability to recycle lignocellulosic matter, may be used to turn this waste into new products, thus generating additional income for essential oil producers. The objectives of our work, within the framework of the European ALCOTRA project FINNOVER, were two-fold. The first was to cultivate Pleurotus ostreatus on solid waste of lavender used for essential oil production. The second was to provide, at the same time, new products that can increase the income of small and medium farms in the Ligurian Italian Riviera. This paper presents two pilot tests in which P. ostreatus was grown on substrates with five different concentrations of lavender waste, ranging from 0 to 100% (w/w). Basidiomata grown on all the substrates and their biochemical profiles were characterized using high-performance liquid chromatography coupled to mass spectrometry. The biochemical analysis of mushrooms proved the presence of molecules with antioxidant and potential pharmacological properties, in particular in mushrooms grown on lavender-enriched substrates. The results open the possibility of producing mushrooms classified as a novel food. Furthermore, the results encourage further experiments aimed at investigating how different substrates positively affect the metabolomics of mushrooms.

There is a growing interest in using brown algal extracts thanks to the bioactive substances they produce for adaptation to the marine benthic environment. We evaluated the anti-aging and photoprotective properties of two types of extracts (50%-ethanol and DMSO) obtained from different portions, i.e., apices and thalli, of the brown seaweed, Ericaria amentacea. The apices of this alga, which grow and develop reproductive structures during summer when solar radiation is at its peak, were postulated to be rich in antioxidant compounds. We determined the chemical composition and pharmacological effects of their extracts and compared them to the thallus-derived extracts. All the extracts contained polyphenols, flavonoids and antioxidants and showed significant biological activities. The hydroalcoholic apices extracts demonstrated the highest pharmacological potential, likely due to the higher content of meroditerpene molecular species. They blocked toxicity in UV-exposed HaCaT keratinocytes and L929 fibroblasts and abated the oxidative stress and the production of pro-inflammatory cytokines, typically released after sunburns. Furthermore, the extracts showed anti-tyrosinase and anti-hydrolytic skin enzyme activity, counteracting the collagenase and hyaluronidase degrading activities and possibly slowing down the formation of uneven pigmentation and wrinkles in aging skin. In conclusion, the E. amentacea apices derivatives constitute ideal components for counteracting sunburn symptoms and for cosmetic anti-aging lotions.

Fungi are often considered a delicacy and are primarily cultivated and harvested, although numerous species are responsible for intoxication due to toxin content. Foodborne diseases are a significant public health concern, causing approximately 420 000 deaths and 600 million morbidities yearly, of which mushroom poisoning is one of the leading causes. Epidemiological data on non-cultivated mushroom poisoning in individual countries are often unrepresentative, as intoxication rarely requires emergency intervention. On the other hand, the lack of specialist knowledge among medical personnel about the toxicological manifestations of mushroom consumption may result in ineffective therapeutic interventions. This work aims to provide an easy-to-consult and wide-ranging tool useful for better understanding the variability of mushroom intoxications, the associated symptoms, and the main treatments for the most severe cases, given the absence of a complete species mapping tool toxic. Moreover, we establish an effective collection network that describes the incidence of mushroom poisonings by reporting the species and associated toxicological manifestations for each case. In conclusion, we highlight the need to establish appropriate primary prevention interventions, such as training the affected population and increasing consultancy relationships between mycological experts and specialised healthcare personnel.

Microplastics (MPs) in drinking water (DW) raise concerns about their potential impacts on health. Several substances, such as plasticizers and stabilizers, can be leached from plastic polymers following abiotic and biotic denaturation processes. Furthermore, the purification treatment of DW, such as the chlorination process, significantly increases the release of chemical components that are part of the polymer composition. Recently, several studies reported that MPs can adsorb environmental xenobiotics, such as organic molecules and heavy metals, thanks to their surface characteristics acquired in the environment in which they are dispersed. This study aims to evaluate the ability of MPs of different sizes (5 µm and 1 µm) oxidized by UVB exposure to adsorb water-dispersed organic pollutants such as benzo-a-pyrene (BaP). We used Fourier transform infrared spectroscopy and Ζ-potential measurements to characterize MPs particles after UVB exposure and gas chromatography-mass spectrometry to determine the adsorptive capacity of oxidized MPs. The analytical results obtained from the present study demonstrate that oxidized MPs have a significant capacity to adsorb BaP dispersed in the aqueous environment and to act as a vehicle for apolar organic substances by concentrating them. This study raises an alert on the dual potential risk determined by the consumption of DW in which MPs can concentrate and convey environmental xenobiotics, in addition to deciding adverse effects related to their chemical-physical properties.

Cystic fibrosis (CF) is a genetic disease affecting the lungs and pancreas and causing progressive damage. CF is caused by mutations abolishing the function of CFTR, a protein whose role is chloride’s mobilization in the epithelial cells of various organs. Recently a therapy focused on small molecules has been chosen as a main approach to contrast CF, designing and synthesizing compounds acting as misfolding (correctors) or defective channel gating (potentiators). Multi-drug therapies have been tested with different combinations of the two series of compounds. Previously, we designed and characterized two series of correctors, namely, hybrids, which were conceived including the aminoarylthiazole (AAT) core, merged with the benzodioxole carboxamide moiety featured by VX-809. In this paper, we herein proceeded with molecular modeling studies guiding the design of a new third series of hybrids, featuring structural variations at the thiazole moiety and modifications on position 4. These derivatives were tested in different assays including a YFP functional assay on models F508del-CFTR CFBE41o-cells, alone and in combination with VX-445, and by using electrophysiological techniques on human primary bronchial epithelia to demonstrate their F508del-CFTR corrector ability. This study is aimed (i) at identifying three molecules (9b, 9g, and 9j), useful as novel CFTR correctors with a good efficacy in rescuing the defect of F508del-CFTR; and (ii) at providing useful information to complete the structure–activity study within all the three series of hybrids as possible CFTR correctors, supporting the development of pharmacophore modelling studies, taking into account all the three series of hybrids. Finally, in silico evaluation of the hybrids pharmacokinetic (PK) properties contributed to highlight hybrid developability as drug-like correctors.